Biocad

biocad is russia’s leading innovative biotechnology company which combines a world-class research and development center, ultra-modern pharmaceutical and biotechnology manufacturing facilities, and pre-clinical and clinical research infrastructure compliant with international standards. biocad is one of the few world’s full-cycle drug development and manufacturing companies, doing everything from new molecules discovery and genetic engineering to large-scale commercial manufacturing and marketing support. biocad’s medicines are used to treat the most complex health conditions, such as cancer, hiv and hepatitis c infections, multiple sclerosis and other disorders. the company employs about 1000 people, 300 out of them scientists and researchers. in 2014 biocad’s sales tripled and reached $200 million, while total amount of long-term international contracts exceeded half a billion us dollars. biocad has subsidiaries in the us, brazil, china, india, singapore, and other countries.